[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full page: (LINK). Abstract, edited.]
------
Volume 18, Number 11?November 2012
Research
Lack of Evidence for Zoonotic Transmission of Schmallenberg Virus
Chantal Reusken<SUP>1</SUP> , Cees van den Wijngaard<SUP>1</SUP>, Paul van Beek, Martin Beer, Ruth Bouwstra, Gert-Jan Godeke, Leslie Isken, Hans van den Kerkhof, Wilfrid van Pelt, Wim van der Poel, Johan Reimerink, Peter Schielen, Jonas Schmidt-Chanasit, Piet Vellema, Ankje de Vries, Inge Wouters, and Marion Koopmans
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (C. Reusken, C. van den Wijngaard, P. van Beek, G.-J. Godeke, L. Isken, H. van den Kerkhof, W. van Pelt, J. Reimerink, P. Schielen, A. de Vries, M. Koopmans); Friedrich-Loeffler-Institut, Insel Riems, Germany (M. Beer); Central Veterinary Institute of Wageningen University and Research Centre, Lelystad, the Netherlands (R. Bouwstra, W. van der Poel); Bernhard Nocht Institute for Tropical Medicine, Hamburg (J. Schmidt-Chanasit); Animal Health Service, Deventer, the Netherlands (P. Vellema); and Institute for Risk Assessment Sciences, Utrecht, the Netherlands (I. Wouters)
Abstract
The emergence of Schmallenberg virus (SBV), a novel orthobunyavirus, in ruminants in Europe triggered a joint veterinary and public health response to address the possible consequences to human health. Use of a risk profiling algorithm enabled the conclusion that the risk for zoonotic transmission of SBV could not be excluded completely. Self-reported health problems were monitored, and a serologic study was initiated among persons living and/or working on SBV-affected farms. In the study set-up, we addressed the vector and direct transmission routes for putative zoonotic transfer. In total, 69 sheep farms, 4 goat farms, and 50 cattle farms were included. No evidence for SBV-neutralizing antibodies was found in serum of 301 participants. The lack of evidence for zoonotic transmission from either syndromic illness monitoring or serologic testing of presumably highly exposed persons suggests that the public health risk for SBV, given the current situation, is absent or extremely low.
-Research
Lack of Evidence for Zoonotic Transmission of Schmallenberg Virus
Chantal Reusken<SUP>1</SUP> , Cees van den Wijngaard<SUP>1</SUP>, Paul van Beek, Martin Beer, Ruth Bouwstra, Gert-Jan Godeke, Leslie Isken, Hans van den Kerkhof, Wilfrid van Pelt, Wim van der Poel, Johan Reimerink, Peter Schielen, Jonas Schmidt-Chanasit, Piet Vellema, Ankje de Vries, Inge Wouters, and Marion Koopmans
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (C. Reusken, C. van den Wijngaard, P. van Beek, G.-J. Godeke, L. Isken, H. van den Kerkhof, W. van Pelt, J. Reimerink, P. Schielen, A. de Vries, M. Koopmans); Friedrich-Loeffler-Institut, Insel Riems, Germany (M. Beer); Central Veterinary Institute of Wageningen University and Research Centre, Lelystad, the Netherlands (R. Bouwstra, W. van der Poel); Bernhard Nocht Institute for Tropical Medicine, Hamburg (J. Schmidt-Chanasit); Animal Health Service, Deventer, the Netherlands (P. Vellema); and Institute for Risk Assessment Sciences, Utrecht, the Netherlands (I. Wouters)
Abstract
The emergence of Schmallenberg virus (SBV), a novel orthobunyavirus, in ruminants in Europe triggered a joint veterinary and public health response to address the possible consequences to human health. Use of a risk profiling algorithm enabled the conclusion that the risk for zoonotic transmission of SBV could not be excluded completely. Self-reported health problems were monitored, and a serologic study was initiated among persons living and/or working on SBV-affected farms. In the study set-up, we addressed the vector and direct transmission routes for putative zoonotic transfer. In total, 69 sheep farms, 4 goat farms, and 50 cattle farms were included. No evidence for SBV-neutralizing antibodies was found in serum of 301 participants. The lack of evidence for zoonotic transmission from either syndromic illness monitoring or serologic testing of presumably highly exposed persons suggests that the public health risk for SBV, given the current situation, is absent or extremely low.
------